Trillium Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
SFM
LAM
BIT
RA
TAM
Trillium Asset Management's ANGO Position: Q3 2014 in Review
Trillium Asset Management sold out of AngioDynamics (ANGO) in Q3 2014, closing a stake of 25,273 shares — an estimated $413K sold.
Trillium Asset Management first reported a position in ANGO in Q2 2013 and held it in 5 quarters. The position peaked at $413K in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.
- Trillium Asset Management reported no remaining AngioDynamics position as of Q3 2014 after selling out during the quarter.
- Trillium Asset Management sold 25,273 AngioDynamics shares in Q3 2014, an estimated $413K.
- Trillium Asset Management first reported a position in AngioDynamics in Q2 2013 and held it in 5 quarters.
- Trillium Asset Management's AngioDynamics position peaked at $413K in Q2 2014.
- 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.
Based on Trillium Asset Management's 13F filing for Q3 2014, filed 21 Oct 2014.